U.S. Companies With Potential Pension Risk Transfer Restructuring Opportunities
Market Whales and Their Recent Bets on Morgan Stanley Options
Bulls Vs. Bears: Is the Schwab U.S. Dividend Equity ETF a Good Investment?
Natural Gas Prices Surge As Arctic Blast Freezes US: 3 Stocks On The Move
GlobalFoundries And IBM Reach Settlement And Resolution Of All Litigation Matters; Details Confidential
Nuclear Power Stocks Expected to Break Out in 2025? Find the investment opportunities here!
(MS) - Analyzing Morgan Stanley's Short Interest
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Brand Prescription Drugs to Rise an Average 4.5% in 2025
Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture?
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Peering Into Bristol-Myers Squibb's Recent Short Interest
Williams Places Into Full Service The Southside Reliability Enhancement, An Expansion And Modernization Of Transco In North Carolina And Virginia
Trim the Mag 7 and Invest in Lower Valuation Dividend Growth Stocks – Miramar Capital
Cold weather exceeded expectations, USA Henry Hub Natural Gas Futures surged over 20% during trading, is inflation cooling down in jeopardy again?
On Monday during Regular Trading Hours, the NYMEX Henry Hub Natural Gas Futures February contract saw its intraday increase expand to 21%, reporting at $4.094 per million British thermal units. This is the largest increase for this contract since it began trading in 2012. Analysis suggests that higher natural gas prices may have macroeconomic implications, which could drive up inflation rates, while severe cold may also suppress Consumer spending in the USA.
Dow Jones 2024 Scoreboard: Top 5 Winners, Losers — And How Amazon, Nvidia Could Reshape 2025
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Top 10 Dividend Stocks With a 2% Yield and Buy or Strong Buy Rating
SA Sentiment: This Energy Sector Is a Popular Choice for 2025
Here Are Morgan Stanley's Key Oncology Catalysts for 2025